Mercier Johanna
SEC CIK 1782135 · EDGAR
BoughtSold
Most active insiders at GILD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | O'Day Daniel Patrick | COB, CEO, Dir | — | $51.34M |
| 2 | Mercier Johanna | Chief Commercial Off | — | $18.52M |
| 3 | Telman Deborah H | EVP, GC, Corp. Affairs | — | $6.59M |
| 4 | Dickinson Andrew D | CFO | — | $4.68M |
| 5 | WELTERS ANTHONY | Dir | — | $2.68M |
| 6 | Bluestone Jeffrey | Dir | — | $1.97M |
| 7 | Kramer Kelly A. | Dir | — | $713.2K |
| 8 | Cain Wettan Keeley M | EVP Gen Counsel, Legal, Comp | — | — |
| 9 | Burkhart Erin | SVP, Controllership | — | — |
| 10 | Berger Dietmar | Chief Medical Off | — | — |
Transactions 85
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2026-09-16 16:27 | 2026-09-15 | GILD | Gilead Sciences | Mercier Johanna | Chief Comm, Corp Aff Off | S - Sale | $144.22 | -3,000 | 116.7K | -3% | -$432.6K |
| D | 2026-09-11 18:28 | 2026-09-10 | GILD | Gilead Sciences | Mercier Johanna | Chief Comm, Corp Aff Off | M - OptEx | — | +2,797 | 121.0K | +2% | — |
| D | 2026-09-11 18:28 | 2026-09-10 | GILD | Gilead Sciences | Mercier Johanna | Chief Comm, Corp Aff Off | F - Tax | $144.81 | -1,347 | 119.7K | -1% | -$195.1K |
| DMT | 2026-08-18 18:54 | 2026-08-17 | GILD | Gilead Sciences | Mercier Johanna | Chief Comm, Corp Aff Off | M - OptEx | $67.07 | +25.0K | 146.2K | +21% | +$1.68M |
| DMT | 2026-08-18 18:54 | 2026-08-17 | GILD | Gilead Sciences | Mercier Johanna | Chief Comm, Corp Aff Off | S - Sale+OE | $137.64 | -28.0K | 118.2K | -19% | -$3.85M |
| T | 2026-07-16 16:54 | 2026-07-15 | GILD | Gilead Sciences | Mercier Johanna | Chief Comm, Corp Aff Off | S - Sale | $129.92 | -3,000 | 121.2K | -2% | -$389.8K |
| MT | 2026-06-16 18:02 | 2026-06-15 | GILD | Gilead Sciences | Mercier Johanna | Chief Comm, Corp Aff Off | S - Sale | $123.92 | -3,000 | 124.2K | -2% | -$371.8K |
| D | 2026-06-11 18:31 | 2026-06-10 | GILD | Gilead Sciences | Mercier Johanna | Chief Comm, Corp Aff Off | M - OptEx | — | +2,796 | 128.6K | +2% | — |
| D | 2026-06-11 18:31 | 2026-06-10 | GILD | Gilead Sciences | Mercier Johanna | Chief Comm, Corp Aff Off | F - Tax | $121.48 | -1,341 | 127.2K | -1% | -$162.9K |
| D | 2026-05-21 19:21 | 2026-05-21 | NBIX | NEUROCRINE BIOSCIENCES INC | Mercier Johanna | Dir | M - OptEx | $0.00 | +3,318 | 6,853 | +94% | $0 |
| DT | 2026-05-18 17:45 | 2026-05-15 | GILD | Gilead Sciences | Mercier Johanna | Chief Comm, Corp Aff Off | M - OptEx | $66.64 | +25.0K | 153.8K | +19% | +$1.67M |
| DMT | 2026-05-18 17:45 | 2026-05-15 | GILD | Gilead Sciences | Mercier Johanna | Chief Comm, Corp Aff Off | S - Sale+OE | $131.29 | -28.0K | 125.8K | -18% | -$3.68M |
| T | 2026-04-16 18:40 | 2026-04-15 | GILD | Gilead Sciences | Mercier Johanna | Chief Comm, Corp Aff Off | S - Sale | $140.96 | -3,000 | 128.8K | -2% | -$422.9K |
| 2026-03-17 | 2026-03-16 | GILD | Gilead Sciences | Mercier Johanna | Chief Comm, Corp Aff Off | S - Sale | $144.23 | -3,000 | 131.8K | -2% | -$432.7K | |
| D | 2026-03-12 | 2026-03-10 | GILD | Gilead Sciences | Mercier Johanna | Chief Comm, Corp Aff Off | M - OptEx | — | +6,617 | 138.0K | +5% | — |
| D | 2026-03-12 | 2026-03-10 | GILD | Gilead Sciences | Mercier Johanna | Chief Comm, Corp Aff Off | F - Tax | $148.56 | -3,216 | 134.8K | -2% | -$477.8K |
| 2026-03-02 | 2026-02-27 | GILD | Gilead Sciences | Mercier Johanna | Chief Comm, Corp Aff Off | A - Grant | $0.00 | +11.1K | 131.4K | +9% | $0 | |
| D | 2026-02-18 | 2026-02-17 | GILD | Gilead Sciences | Mercier Johanna | Chief Comm, Corp Aff Off | M - OptEx | $66.64 | +25.0K | 148.3K | +20% | +$1.67M |
| DM | 2026-02-18 | 2026-02-17 | GILD | Gilead Sciences | Mercier Johanna | Chief Comm, Corp Aff Off | S - Sale+OE | $154.44 | -28.0K | 120.3K | -19% | -$4.32M |
| 2026-02-05 | 2026-02-03 | GILD | Gilead Sciences | Mercier Johanna | Chief Comm, Corp Aff Off | F - Tax | $143.28 | -24.8K | 123.3K | -17% | -$3.55M | |
| 2026-02-05 | 2026-02-03 | GILD | Gilead Sciences | Mercier Johanna | Chief Comm, Corp Aff Off | A - Grant | $0.00 | +44.9K | 148.1K | +43% | $0 | |
| 2026-01-16 | 2026-01-15 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | S - Sale | $124.31 | -3,000 | 103.2K | -3% | -$372.9K | |
| 2025-12-16 | 2025-12-15 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | S - Sale | $122.00 | -3,000 | 106.2K | -3% | -$366.0K | |
| D | 2025-12-11 | 2025-12-10 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | F - Tax | $121.34 | -1,814 | 109.2K | -2% | -$220.1K |
| D | 2025-12-11 | 2025-12-10 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | M - OptEx | — | +3,842 | 111.0K | +4% | — |
| D | 2025-11-18 | 2025-11-17 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | M - OptEx | $66.64 | +25.0K | 135.2K | +23% | +$1.67M |
| DM | 2025-11-18 | 2025-11-17 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | S - Sale+OE | $125.87 | -28.0K | 109.7K | -20% | -$3.52M |
| 2025-10-16 | 2025-10-15 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | S - Sale | $118.08 | -3,000 | 110.2K | -3% | -$354.2K | |
| 2025-09-16 | 2025-09-15 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | S - Sale | $113.57 | -3,000 | 113.2K | -3% | -$340.7K | |
| D | 2025-09-11 | 2025-09-10 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | M - OptEx | — | +3,844 | 118.0K | +3% | — |
| D | 2025-09-11 | 2025-09-10 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | F - Tax | $115.25 | -1,819 | 116.2K | -2% | -$209.6K |
| DM | 2025-08-18 | 2025-08-15 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | S - Sale+OE | $118.53 | -28.0K | 117.2K | -19% | -$3.32M |
| DM | 2025-08-18 | 2025-08-15 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | M - OptEx | $66.64 | +25.0K | 129.0K | +24% | +$1.67M |
| 2025-07-16 | 2025-07-15 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | S - Sale | $111.03 | -3,000 | 117.2K | -2% | -$333.1K | |
| 2025-06-17 | 2025-06-16 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | S - Sale | $110.17 | -3,000 | 120.2K | -2% | -$330.5K | |
| D | 2025-06-11 | 2025-06-10 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | F - Tax | $110.09 | -1,827 | 123.2K | -1% | -$201.1K |
| D | 2025-06-11 | 2025-06-10 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | M - OptEx | — | +3,843 | 125.0K | +3% | — |
| DM | 2025-05-23 | 2025-05-22 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | M - OptEx | $66.64 | +25.0K | 136.7K | +22% | +$1.67M |
| DM | 2025-05-23 | 2025-05-22 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | S - Sale+OE | $107.52 | -28.0K | 124.2K | -18% | -$3.01M |
| D | 2025-05-22 | 2025-05-22 | NBIX | NEUROCRINE BIOSCIENCES INC | Mercier Johanna | Dir | M - OptEx | $0.00 | +1,435 | 3,535 | +68% | $0 |
| D | 2025-03-12 | 2025-03-10 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | F - Tax | $117.21 | -3,907 | 124.2K | -3% | -$457.9K |
| D | 2025-03-12 | 2025-03-10 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | M - OptEx | — | +8,080 | 128.1K | +7% | — |
| M | 2025-02-06 | 2025-02-04 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | A - Grant | $0.00 | +90.5K | 94.9K | +2,044% | $0 |
| 2025-02-06 | 2025-02-04 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | F - Tax | $97.99 | -45.7K | 120.0K | -28% | -$4.47M | |
| D | 2024-12-11 | 2024-12-10 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | M - OptEx | — | +3,752 | 76.9K | +5% | — |
| D | 2024-12-11 | 2024-12-10 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | F - Tax | $92.34 | -1,739 | 75.1K | -2% | -$160.6K |
| 2024-11-07 | 2024-11-06 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | S - Sale | $91.28 | -5,000 | 73.1K | -6% | -$456.4K | |
| M | 2024-09-13 | 2024-09-12 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | S - Sale | $83.78 | -29.4K | 78.1K | -27% | -$2.46M |
| D | 2024-09-11 | 2024-09-10 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | F - Tax | $81.44 | -1,734 | 107.5K | -2% | -$141.2K |
| D | 2024-09-11 | 2024-09-10 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | M - OptEx | — | +3,752 | 109.2K | +4% | — |
| 2024-08-29 | 2024-08-28 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | S - Sale | $78.03 | -9,513 | 105.5K | -8% | -$742.3K | |
| 2024-08-14 | 2024-08-13 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | S - Sale | $73.98 | -5,490 | 115.0K | -5% | -$406.2K | |
| D | 2024-06-11 | 2024-06-10 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | F - Tax | $65.25 | -1,714 | 120.5K | -1% | -$111.8K |
| D | 2024-06-11 | 2024-06-10 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | M - OptEx | — | +3,751 | 122.2K | +3% | — |
| D | 2024-05-21 | 2024-05-17 | NBIX | NEUROCRINE BIOSCIENCES INC | Mercier Johanna | Dir | M - OptEx | $0.00 | +2,100 | 2,100 | New | $0 |
| DM | 2024-03-11 | 2024-03-10 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | M - OptEx | — | +9,844 | 123.0K | +9% | — |
| D | 2024-03-11 | 2024-03-10 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | F - Tax | $75.12 | -4,559 | 118.4K | -4% | -$342.5K |
| 2024-02-02 | 2024-01-31 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | F - Tax | $78.26 | -22.5K | 113.1K | -17% | -$1.76M | |
| M | 2024-02-02 | 2024-01-31 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | A - Grant | $0.00 | +74.1K | 81.7K | +970% | $0 |
| 2024-01-10 | 2024-01-09 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | S - Sale | $85.23 | -8,242 | 82.7K | -9% | -$702.5K | |
| D | 2023-12-11 | 2023-12-10 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | F - Tax | $79.02 | -1,247 | 91.0K | -1% | -$98.5K |
| D | 2023-12-11 | 2023-12-10 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | M - OptEx | — | +2,730 | 92.2K | +3% | — |
| D | 2023-09-11 | 2023-09-10 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | M - OptEx | — | +2,730 | 90.7K | +3% | — |
| D | 2023-09-11 | 2023-09-10 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | F - Tax | $76.00 | -1,256 | 89.5K | -1% | -$95.5K |
| D | 2023-07-25 | 2023-07-24 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | F - Tax | $77.66 | -3,174 | 48.3K | -6% | -$246.5K |
| D | 2023-07-25 | 2023-07-24 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | M - OptEx | — | +7,505 | 51.5K | +17% | — |
| D | 2023-06-12 | 2023-06-10 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | M - OptEx | — | +2,730 | 45.3K | +6% | — |
| D | 2023-06-12 | 2023-06-10 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | F - Tax | $78.12 | -1,272 | 44.0K | -3% | -$99.4K |
| DM | 2023-03-13 | 2023-03-10 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | M - OptEx | — | +11.0K | 79.4K | +16% | — |
| D | 2023-03-13 | 2023-03-10 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | F - Tax | $79.50 | -5,116 | 82.2K | -6% | -$406.7K |
| M | 2023-01-26 | 2023-01-24 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | A - Grant | $0.00 | +67.4K | 53.4K | New | $0 |
| 2023-01-26 | 2023-01-24 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | F - Tax | $84.02 | -15.3K | 76.4K | -17% | -$1.29M | |
| D | 2022-12-13 | 2022-12-10 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | M - OptEx | — | +990 | 40.9K | +2% | — |
| D | 2022-12-13 | 2022-12-10 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | F - Tax | $87.97 | -463 | 40.4K | -1% | -$40.7K |
| D | 2022-09-12 | 2022-09-10 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | F - Tax | $65.28 | -458 | 39.9K | -1% | -$29.9K |
| D | 2022-09-12 | 2022-09-10 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | M - OptEx | — | +990 | 40.4K | +3% | — |
| D | 2022-07-26 | 2022-07-24 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | F - Tax | $60.80 | -3,206 | 39.4K | -8% | -$194.9K |
| D | 2022-07-26 | 2022-07-24 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | M - OptEx | — | +7,505 | 42.6K | +21% | — |
| D | 2022-06-13 | 2022-06-10 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | F - Tax | $60.74 | -462 | 35.1K | -1% | -$28.1K |
| D | 2022-06-13 | 2022-06-10 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | M - OptEx | — | +990 | 35.5K | +3% | — |
| DM | 2022-03-14 | 2022-03-10 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | M - OptEx | $0.00 | +6,987 | 37.8K | +23% | $0 |
| D | 2022-03-14 | 2022-03-10 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | F - Tax | $57.92 | -3,221 | 34.5K | -9% | -$186.6K |
| 2022-01-28 | 2022-01-26 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | A - Grant | $0.00 | +18.6K | 30.8K | +153% | $0 | |
| D | 2021-07-27 | 2021-07-24 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | F - Tax | $69.02 | -3,425 | 12.1K | -22% | -$236.4K |
| D | 2021-07-27 | 2021-07-24 | GILD | Gilead Sciences | Mercier Johanna | Chief Commercial Off | M - OptEx | — | +7,505 | 15.6K | +93% | — |
Purchase Sale Sale after option exercise All abbreviations